Seán Crowe (Dublin South West, Sinn Fein) | Oireachtas source

What is the HSE's view on participation in clinical trials for rare diseases? The witnesses are predicting that they will improve access to and quality of care in an Irish context. Could they elaborate on that? This question is for me, as well as for the people who are listening at home.